350 related articles for article (PubMed ID: 33714984)
1. CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation.
Chen T; Wang X; Li C; Zhang H; Liu Y; Han D; Li Y; Li Z; Luo D; Zhang N; Zheng M; Chen B; Wang L; Zhao W; Yang Q
Oncogene; 2021 Apr; 40(15):2756-2771. PubMed ID: 33714984
[TBL] [Abstract][Full Text] [Related]
2. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro.
Wang M; Chen D; Zhang H; Luo C
Inflamm Res; 2022 Apr; 71(4):409-421. PubMed ID: 35234989
[TBL] [Abstract][Full Text] [Related]
4. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
5. Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback loop.
Song H; Zhao Z; Ma L; Zhao W; Hu Y; Song Y
Oncogene; 2024 Mar; 43(11):821-836. PubMed ID: 38280941
[TBL] [Abstract][Full Text] [Related]
6. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
[TBL] [Abstract][Full Text] [Related]
7. CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration.
Geng Y; Zheng X; Zhang D; Wei S; Feng J; Wang W; Zhang L; Wu C; Hu W
Biol Direct; 2024 May; 19(1):36. PubMed ID: 38715141
[TBL] [Abstract][Full Text] [Related]
8. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.
Yang SJ; Wang DD; Zhong SL; Chen WQ; Wang FL; Zhang J; Xu WX; Xu D; Zhang Q; Li J; Zhang HD; Hou JC; Mao L; Tang JH
Cell Death Dis; 2021 Apr; 12(5):420. PubMed ID: 33911067
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
Wang X; Xue B; Zhang Y; Guo G; Duan X; Dou D
Cell Death Dis; 2021 Apr; 12(5):412. PubMed ID: 33875646
[TBL] [Abstract][Full Text] [Related]
11. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation.
Li Y; Wang Z; Yang J; Sun Y; He Y; Wang Y; Chen X; Liang Y; Zhang N; Wang X; Zhao W; Hu G; Yang Q
Mol Cancer; 2024 May; 23(1):102. PubMed ID: 38755678
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
[TBL] [Abstract][Full Text] [Related]
13. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.
Lyu L; Zhang S; Deng Y; Wang M; Deng X; Yang S; Wu Y; Dai Z
J Hematol Oncol; 2021 Mar; 14(1):41. PubMed ID: 33676555
[TBL] [Abstract][Full Text] [Related]
15. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
17. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis.
Xu JZ; Shao CC; Wang XJ; Zhao X; Chen JQ; Ouyang YX; Feng J; Zhang F; Huang WH; Ying Q; Chen CF; Wei XL; Dong HY; Zhang GJ; Chen M
Cell Death Dis; 2019 Feb; 10(3):175. PubMed ID: 30787278
[TBL] [Abstract][Full Text] [Related]
18. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
19. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
[TBL] [Abstract][Full Text] [Related]
20. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]